ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985

Greenberg Named UT System Vice Chancellor For Health Affairs

July 19, 2013

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013

Sausville to lead clinical research at Maryland.

December 5, 2003

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012